State Of Wyoming Design Therapeutics, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$9.91 - $17.33 $287 - $502	29 Added 31.18%	122 $2,000
Q1 2022 May 13, 2022	BUY	$11.17 - $20.89 $178 - $334	16 Added 20.78%	93 $2,000
Q4 2021 Feb 11, 2022	SELL	$13.64 - $21.41 $54 - $85	-4 Reduced 4.94%	77 $2,000
Q3 2021 Feb 11, 2022	SELL	$13.99 - $20.03 $559 - $801	-40 Reduced 33.06%	81 $1,000
Q2 2021 Feb 11, 2022	BUY	$19.02 - $29.78 $2,301 - $3,603	121 New	121 $2,000

103

30.8M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $277M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.